Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamide.
Rimondo A, Bramanti S, Crocchiolo R, Giordano L, Sarina B, Morabito L, Perotti C, Timofeeva I, Capizzuto R, Santoro A, Castagna L.
Vox Sang. 2016 Jul;111(1):93-100. doi: 10.1111/vox.12385. Epub 2016 Feb 25.
Validation plan of bone marrow collection, processing and distribution using the failure mode and effect analysis methodology: a technical report.
Teofili L, Bianchi M, Valentini CG, Bartolo M, Orlando N, Sica S.
Cytotherapy. 2022 Mar;24(3):356-364. doi: 10.1016/j.jcyt.2021.10.005. Epub 2021 Dec 2.
Graft Source Choice.
Hong S, Horwitz ME.
Adv Exp Med Biol. 2025;1475:57-75. doi: 10.1007/978-3-031-84988-6_4.
Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.
Siddiq S, Pamphilon D, Brunskill S, Doree C, Hyde C, Stanworth S.
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006406. doi: 10.1002/14651858.CD006406.pub2.
Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience.
Fernandez-Sojo J, Valdivia E, Esquirol A, Portos JM, Rovira M, Suarez M, Diaz-de-Heredia C, Uría ML, Ortí G, Ferra C, Mussetti A, Paviglianiti A, Marsal J, Badell I, Lozano M, Gomez D, Azqueta C, Martorell L, Rubio N, Garcia-Buendia A, Villa J, Carreras E, Querol S.
Vox Sang. 2023 Sep;118(9):783-789. doi: 10.1111/vox.13499. Epub 2023 Aug 2.
Bone Marrow Quality Index: A Predictor of Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplantation for Thalassemia.
Agarwal RK, Dhanya R, Sedai A, Ankita K, Parmar L, Ramprakash S, Sandeep, Trivedi D, Shah V, Bhat N, Reddy M, R N, Faulkner L.
Transplant Cell Ther. 2023 Nov;29(11):711.e1-711.e6. doi: 10.1016/j.jtct.2023.07.014. Epub 2023 Jul 21.
Bone marrow transplantation.
van Bekkum DW.
Transplant Proc. 1977 Mar;9(1):147-54.
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA.
Biol Blood Marrow Transplant. 2015 Oct;21(10):1830-8. doi: 10.1016/j.bbmt.2015.06.013. Epub 2015 Jun 23.
Impact of donor characteristics on the quality of bone marrow as a source of mesenchymal stromal cells.
Barreto-Durán E, Mejía-Cruz CC, Leal-García E, Pérez-Núñez R, Rodríguez-Pardo VM.
Am J Stem Cells. 2018 Dec 1;7(5):114-120. eCollection 2018.
Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34(+) Yields Are Less.
Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA.
Biol Blood Marrow Transplant. 2018 Jan;24(1):175-184. doi: 10.1016/j.bbmt.2017.09.013. Epub 2017 Sep 25.
